Differ Group Auto Limited — Board/Management Information 2021

Dec 9, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

DIFFER GROUP HOLDING COMPANY LIMITED 鼎豐集團控股有限公司

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 6878)

APPOINTMENT OF EXECUTIVE DIRECTOR

The Board is pleased to announce that Dr. Feng has been appointed as an executive director of the Company with effect from 9 December 2021.

The announcement is made by Differ Group Holding Company Limited (the “ Company ”) pursuant to Rule 13.51(2) of the Rules (the “ Listing Rules ”) Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Hong Kong Stock Exchange ”).

The board (the “ Board ”) of directors (the “ Director ”) is pleased to announce that Dr. Feng Xiaogang (“ Dr. Feng ”) has been appointed as an executive director of the Company with effect from 9 December 2021.

The biographic details of Dr. Feng are as follows:

Dr. Feng, aged 56, holds a Bachelor of Law degree from Tianjin Normal University, a Master of Business Administration degree from the University of Science and Technology Beijing and a Doctor of Philosophy degree in Management from Twintech International University College of Technology. Dr. Feng currently acts as an investment consultant for various companies in the People’s Republic of China (the “ PRC ”) and overseas. Dr. Feng has extensive experience in management and investment.

During the period from 2001 to 2013, Dr. Feng was a senior management of Ambow Education Holding Ltd. (“ Ambow Education ”), a company listed on the New York Stock Exchange. During his tenure at Ambow Education, Dr. Feng led various fund raising, mergers and acquisitions projects. Prior to joining Ambow Education, Dr. Feng also worked in a government entity in the PRC and various international companies and was mainly responsible for investment and business management.

1

Dr. Feng is currently the chairman and an executive director of Courage Investment Group Limited (Hong Kong stock code: 1145 and Singapore stock code: CIN), a company listed on the Main Board of the Hong Kong Stock Exchange and the Singapore Stock Exchange. Dr. Feng was also an executive director of Tack Fiori International Group Limited (now known as Life Healthcare Group Limited) (stock code: 928), a company listed on the Main Board of the Hong Kong Stock Exchange, until 15 February 2016 when he was re-designated as a non- executive director and served until 31 October 2019.

Pursuant to the service contract entered into between the Company and Dr. Feng, (i) Dr. Feng is not appointed for any specific length or proposed length of service and his term of service shall continue unless and until terminated by either party giving to the other not less than three months’ prior written notice; (ii) Dr. Feng’s term of office as executive director shall also be subject to retirement and re-election at the annual general meeting in accordance with the articles of association of the Company; and (iii) Dr. Feng is entitled to receive a remuneration of HK$50,000 per month which were determined by the Board upon recommendation from the Remuneration Committee of the Company with reference to the prevailing market rate, the Company’s remuneration policy, his duties and responsibilities with the Company and his contribution to the Company.

Save as disclosed above, as at the date of this announcement, Dr. Feng (i) does not hold any other position with the Company or any of its subsidiaries; (ii) does not hold any other directorships in any other listed public companies in Hong Kong or overseas in the last three years; (iii) does not have any relationship with any Director, senior management or substantial or controlling shareholders of the Company; (iv) does not have or is not deemed to have any interests or short positions in the shares or underlying shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Save as disclosed above, Dr. Feng confirmed that there are no other matters concerning the appointment of Dr. Feng that need to be brought to the attention of the shareholders of the Company and there is no other information in respect of Dr. Feng which is disclosable pursuant to Rule 13.51(2)(h) to (v) of the Listing Rules.

The Board would like to take this opportunity to welcome Dr. Feng as a new Board member and look forward to Dr. Feng bringing to the Company more strategic directions and visions.

By order of the Board Differ Group Holding Company Limited Hong Mingxian Chairman and Executive Director

Hong Kong, 9 December 2021

As at the date of this announcement, the executive Directors are Mr. HONG Mingxian, Mr. NG Chi Chung and Dr. FENG Xiaogang; the non-executive Directors are Mr. CAI Huatan and Mr. WU Qinghan; and the independent non-executive Directors are Mr. CHAN Sing Nun, Mr. LAM Kit Lam and Mr. CHEN Naike.

2